QUICKI Calculator
Free Quickicalculator Calculator with medically-sourced formulas. Enter your measurements for personalized, accurate health insights.
Formula
QUICKI = 1 / (log10(Fasting Insulin) + log10(Fasting Glucose))
Where Fasting Insulin is in microU/mL and Fasting Glucose is in mg/dL. Higher QUICKI values indicate better insulin sensitivity. Normal is above 0.382, borderline is 0.339-0.382, and below 0.339 indicates insulin resistance. Below 0.30 signifies significant resistance.
Worked Examples
Example 1: Normal Insulin Sensitivity
Problem: Calculate QUICKI for a patient with fasting glucose of 85 mg/dL and fasting insulin of 5 microU/mL.
Solution: QUICKI = 1 / (log10(5) + log10(85))\nQUICKI = 1 / (0.6990 + 1.9294)\nQUICKI = 1 / 2.6284\nQUICKI = 0.3805\nHOMA-IR = (4.72 x 5) / 22.5 = 1.05\nThis indicates borderline-normal insulin sensitivity
Result: QUICKI = 0.3805 (Borderline Normal) | HOMA-IR = 1.05 | Good sensitivity
Example 2: Insulin Resistance Detection
Problem: Calculate QUICKI for a patient with fasting glucose of 120 mg/dL and fasting insulin of 25 microU/mL.
Solution: QUICKI = 1 / (log10(25) + log10(120))\nQUICKI = 1 / (1.3979 + 2.0792)\nQUICKI = 1 / 3.4771\nQUICKI = 0.2876\nHOMA-IR = (6.66 x 25) / 22.5 = 7.40\nSignificant insulin resistance detected
Result: QUICKI = 0.2876 (Low) | HOMA-IR = 7.40 | Significant insulin resistance
Frequently Asked Questions
What is the QUICKI index and how does it measure insulin sensitivity?
QUICKI stands for Quantitative Insulin Sensitivity Check Index. It is a mathematical formula that estimates insulin sensitivity using fasting glucose and fasting insulin levels from a single blood draw. Developed by Katz et al. in 2000, QUICKI uses a logarithmic transformation to linearize the relationship between insulin and glucose, providing a more normally distributed measure compared to HOMA-IR. The formula is QUICKI = 1 / (log10 fasting insulin + log10 fasting glucose). Higher QUICKI values indicate better insulin sensitivity, with normal values typically above 0.382. QUICKI has been validated against the gold standard euglycemic-hyperinsulinemic clamp and shows correlation coefficients of 0.78-0.89, making it one of the most accurate surrogate measures available.
How is QUICKI calculated and what do the numbers mean?
QUICKI is calculated as the inverse of the sum of the base-10 logarithms of fasting insulin (in microU/mL) and fasting glucose (in mg/dL). The logarithmic transformation is key because the relationship between insulin and glucose is nonlinear, and log transformation produces a more linear and normally distributed output. Normal QUICKI values range from 0.382 to 0.450, with higher values indicating greater insulin sensitivity. Values between 0.339 and 0.382 suggest borderline insulin sensitivity. Values below 0.339 indicate insulin resistance, and values below 0.30 suggest significant insulin resistance associated with metabolic syndrome. Unlike HOMA-IR where higher values indicate worse outcomes, higher QUICKI values indicate better insulin sensitivity.
How does QUICKI compare to HOMA-IR for measuring insulin resistance?
QUICKI and HOMA-IR are mathematically related but use different transformations. HOMA-IR multiplies glucose by insulin and divides by a constant, while QUICKI uses logarithmic transformation. Several comparative studies have shown that QUICKI correlates more closely with clamp-derived insulin sensitivity than HOMA-IR, particularly in obese individuals and those with significantly impaired insulin sensitivity. The logarithmic transformation in QUICKI better captures the nonlinear relationship between insulin and glucose at extreme values. However, both measures use the same input data (fasting glucose and insulin), so they are highly correlated with each other. Many researchers report both values for completeness. QUICKI is particularly favored in research settings due to its better statistical properties and normal distribution.
What factors can affect QUICKI results and how can accuracy be improved?
Several factors affect QUICKI accuracy. The most important is proper fasting: patients must fast for 8-12 hours, and samples should be drawn in the morning between 7-10 AM to minimize circadian variation. Stress, poor sleep, and acute illness can elevate cortisol and catecholamines, affecting both glucose and insulin levels. Certain medications including steroids, beta-blockers, thiazide diuretics, and atypical antipsychotics can alter insulin sensitivity and should be noted when interpreting results. Hemolysis of the blood sample can falsely lower insulin measurements. For maximum reliability, consider averaging results from two or three separate fasting blood draws taken on different days. The coefficient of variation for QUICKI is approximately 10-15%, meaning small changes between measurements may not be clinically significant.
Can QUICKI be used to monitor treatment response over time?
QUICKI is an excellent tool for monitoring treatment response because it is sensitive to changes in insulin sensitivity induced by interventions. Weight loss studies have shown that QUICKI values increase by 0.02-0.05 points with 5-10% body weight reduction, reflecting improved insulin sensitivity. Exercise interventions typically improve QUICKI by 0.01-0.03 points within 8-12 weeks. Metformin treatment can increase QUICKI by 0.02-0.04 points, while thiazolidinediones may improve it by 0.03-0.06 points. When monitoring treatment response, consistent testing conditions are critical for comparing values over time. A clinically meaningful change in QUICKI is generally considered to be at least 0.02 points, given the inherent biological variability.
What is the revised QUICKI and how does it differ from standard QUICKI?
The revised QUICKI (rQUICKI) adds a third variable, fasting free fatty acids (FFA), to the standard formula: rQUICKI = 1 / (log10 insulin + log10 glucose + log10 FFA). The inclusion of free fatty acids improves the accuracy of insulin sensitivity estimation because FFAs play a critical role in insulin resistance through lipotoxicity and impaired insulin signaling pathways. Studies have shown that rQUICKI correlates even more strongly with clamp-derived insulin sensitivity than standard QUICKI, particularly in obese individuals and those with non-alcoholic fatty liver disease. However, rQUICKI requires an additional lab measurement that is not routinely available, limiting its practical application in clinical settings compared to the standard QUICKI formula.